There's Only One Way to Stop the Emergence of Variants Like Omicron

"This crisis is far from over, and without dramatic course correction, will go on for some time."

Two asian woman doctor in personal protective suit or PPE with mask writing on quarantine patient chart, holding test tube with blood sample for screening coronavirus.


There are still more questions about the Omicron variant than answers. While the mutations identified suggest it has the potential to be more resistant to vaccines, invade cells more efficiently and be more transmissible than other variants, it may also turn out to cause less severe disease or it could just simply fizzle out. However, what it does tell us is that so long as there are large populations of unvaccinated people enabling the virus to spread and mutate unabated, worrying new variants of concern like this will continue to emerge. Once again, as borders close and stock markets tumble, it tells us that this crisis is far from over, and without dramatic course correction, will go on for some time.

Given the rising levels of infection, the global shortage in ICU beds, the resumption of lockdowns and the riots, that much should already be obvious. And yet there is a growing perception – particularly in countries with high vaccine coverage where life appears to be returning to something close to normal – that COVID-19 has somehow become or is close to becoming endemic. That in itself is a concern, but a bigger worry now is that Omicron will trigger a knee-jerk response and a repeat of past mistakes. If the priority becomes to provide variant-specific boosters for people who are already protected, diverting efforts and resources from getting first doses to the 3.6 billion people who are still unvaccinated, then we could face a seemingly endless cycle of resurgences and new variants.

If, as now seems likely, we won’t be able to eliminate this virus entirely, then the COVID-19 endgame will indeed mean that it eventually does become endemic – ever present, but with stabler and much lower levels of transmission and infection, much like flu. When that does happen, regular boosters will no doubt become the norm. But we are not anywhere near that stage yet. So, while it is encouraging and important that manufacturers are already working on Omicron-specific boosters, this cannot come at the expense of protecting those still most at risk, particularly those at highest risk, namely people who are still not vaccinated.

At this stage in the pandemic, COVID-19 has effectively become a disease of the unvaccinated. Because up until now vaccines have been incredibly effective at preventing severe disease and death, even against variants that have shown some resistance to vaccines like Delta. With Omicron it’s possible that that effectiveness could be reduced with existing vaccines, while boosters may offer some enhanced protection. But even if that is the case, what is likely to have the most impact on the pandemic: providing additional protection through third or fourth shots to people who are already at an extremely low risk or pouring efforts into reaching the billions of people who have still not had their first shot?

Continue reading the original TIME article here.


First published in Time on 29 November